Hosts: UNESCO Chair on Bioethics, MUW/Josephinum, in cooperation with Ethikplattform BOKU and CERMEL

CRISPR/Cas9 is the most efficient new tool for genome editing. It is simple and cost-effective. There is great hope for curing severe genetic diseases using CRISPR/Cas9. Moreover, there are several ground-breaking practical applications possible such as improved somatic gene therapy, germline modification, and management of disease-bearing insect populations (e.g. mosquitos) in the wild.

While scientists are working to establish technical safety of CRISPR/Cas9 i.e. to minimize or even eliminate off-target effects, we also need to consider the ethical, medical, and legal implications of such interventions.

Since its publication by Jennifer Doudna and Emmanuelle Charpentier in Science 2012, the scientific community has discussed ethical issues, in particular those which affect following generations: Special focus has been given to germline modifications. But there is another application, the modification of insect populations, namely the “gene drive” system targeting female reproduction in the malaria mosquito vector Anopheles gambiae.

As human beings we have a moral duty towards ourselves, but also to conserve and protect the integrity of the ecosystem. This conference is a follow-up meeting of the INSERM Conference in March 2016 in Paris. It is focussed on the influence and the ethical and societal consequences of this potential malaria control tool, on the burden of disease and the environment. Its goal is to develop recommendations for further research in this area.


Speakers’ Presentations

Vortragsfolien „Comparing CRISPR/Cas9 with other Techniques: Aspects of Prospective Technology Assessment“ (W. Liebert, Ethikplattform BOKU)

Zusammenfassung des Vortrags von Wolfgang Liebert